300015 爱尔眼科
已收盘 05-07 15:00:00
资讯
新帖
简况
爱尔眼科：公司在2023年年报中披露了“商誉账面原值”表与“商誉减值准备”表
证券之星 · 05-07 19:01
爱尔眼科：公司在2023年年报中披露了“商誉账面原值”表与“商誉减值准备”表
爱尔眼科(300015.SZ)累计回购1131.04万股 耗资2.04亿元
智通财经 · 05-06 20:30
爱尔眼科(300015.SZ)累计回购1131.04万股 耗资2.04亿元
西南证券：给予爱尔眼科买入评级
证券之星 · 05-05 10:00
西南证券：给予爱尔眼科买入评级
触及十年估值谷底，爱尔眼科否极泰来？
格隆汇APP · 04-27
触及十年估值谷底，爱尔眼科否极泰来？
爱尔眼科：公司严格按照药监部门的要求，根据患者实际情况使用硫酸阿托品滴眼液院内制剂
证券之星 · 04-26
爱尔眼科：公司严格按照药监部门的要求，根据患者实际情况使用硫酸阿托品滴眼液院内制剂
平安证券：给予爱尔眼科增持评级
证券之星 · 04-26
平安证券：给予爱尔眼科增持评级
国金证券：给予爱尔眼科买入评级
证券之星 · 04-26
国金证券：给予爱尔眼科买入评级
图解爱尔眼科一季报：第一季度单季净利润同比增15.16%
证券之星 · 04-26
图解爱尔眼科一季报：第一季度单季净利润同比增15.16%
爱尔眼科(300015.SZ)发布一季度业绩，净利润8.99亿元 同比增加15.16%
智通财经 · 04-25
爱尔眼科(300015.SZ)发布一季度业绩，净利润8.99亿元 同比增加15.16%
4月25日爱尔眼科现1笔折价21.57%的大宗交易 合计成交240万元
证券之星 · 04-25
4月25日爱尔眼科现1笔折价21.57%的大宗交易 合计成交240万元
4月23日爱尔眼科现1笔折价20.53%的大宗交易 合计成交240万元
证券之星 · 04-23
4月23日爱尔眼科现1笔折价20.53%的大宗交易 合计成交240万元
爱尔眼科：谢谢您对公司的关注和建议，我们会认真考虑
证券之星 · 04-22
爱尔眼科：谢谢您对公司的关注和建议，我们会认真考虑
4月22日爱尔眼科现1笔折价16.94%的大宗交易 合计成交308.45万元
证券之星 · 04-22
4月22日爱尔眼科现1笔折价16.94%的大宗交易 合计成交308.45万元
脑机接口又传重磅利好！全球最大神经拟态系统诞生，比人脑快200倍
格隆汇 · 04-22
脑机接口又传重磅利好！全球最大神经拟态系统诞生，比人脑快200倍
稳市场重心或转向成长？创大盘ETF（159991）逆市收涨4.06%，权重股爱尔眼科、宁德时代领衔反弹
新浪基金 · 02-05
稳市场重心或转向成长？创大盘ETF（159991）逆市收涨4.06%，权重股爱尔眼科、宁德时代领衔反弹
医药、科技联袂齐升，创大盘ETF（159991）午后一度涨超5%！天孚通信、爱尔眼科等股涨逾7%
新浪基金 · 02-05
医药、科技联袂齐升，创大盘ETF（159991）午后一度涨超5%！天孚通信、爱尔眼科等股涨逾7%
爱尔眼科为何突现股价异动？
市场资讯 · 01-25
爱尔眼科为何突现股价异动？
爱尔眼科：免去贵港爱尔CEO职务、暂停涉事医生院长职务
市场资讯 · 2023-12-22
爱尔眼科：免去贵港爱尔CEO职务、暂停涉事医生院长职务
爱尔眼科深夜声明！免去贵港爱尔CEO职务
券商中国 · 2023-12-22
爱尔眼科深夜声明！免去贵港爱尔CEO职务
深陷舆论漩涡，爱尔眼科的“眼科帝国”还好吗？
财华社 · 2023-12-21
深陷舆论漩涡，爱尔眼科的“眼科帝国”还好吗？
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":13.22,"timestamp":1715065383000,"preClose":13.34,"halted":0,"volume":64955554,"delay":0,"floatShares":7905000000,"shares":9328000000,"eps":0.3728,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.12,"latestTime":"05-07 15:00:00","open":13.34,"high":13.34,"low":13.16,"amount":859000000,"amplitude":0.0135,"askPrice":13.22,"askSize":161,"bidPrice":13.21,"bidSize":4929,"shortable":0,"etf":0,"ttmEps":0.3728,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715131800000},"adr":0,"adjPreClose":13.34,"symbolType":"stock","openAndCloseTimeList":[[1715045400000,1715052600000],[1715058000000,1715065200000]],"highLimit":14.67,"lowLimit":12.01,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9328411413,"pbRate":6.32,"roa":"--","roe":"4.67%","epsLYR":0.3644,"committee":0.317067,"marketValue":123322000000,"floatMarketCap":104504000000,"peRate":35.461374,"changeRate":-0.009,"turnoverRate":0.0082,"status":1},"requestUrl":"/m/hq/s/300015/wiki","defaultTab":"wiki","newsList":[{"id":"2433271208","title":"爱尔眼科：公司在2023年年报中披露了“商誉账面原值”表与“商誉减值准备”表","url":"https://stock-news.laohu8.com/highlight/detail?id=2433271208","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433271208?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:01","pubTimestamp":1715079716,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科05月07日在投资者关系平台上答复投资者关心的问题。投资者：大连爱尔在2020年被收购时，形成商誉3264万，这几年一直在发生商誉减值，累计减值额已经达到3264万，此时大连爱尔的商誉应该已经清零，为什么在商誉表中，依然维持3264万保持不变？公司在2023年年报中披露了“商誉账面原值”表与“商誉减值准备”表。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700031917.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433206304","title":"爱尔眼科(300015.SZ)累计回购1131.04万股 耗资2.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433206304","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433206304?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:30","pubTimestamp":1714998623,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)公告，公司以集中竞价交易方式回购公司股份1131.04万股，占公司总股本的比例为0.12%，成交总金额为2.04亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117837.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433177266","title":"西南证券：给予爱尔眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433177266","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433177266?lang=zh_cn&edition=full","pubTime":"2024-05-05 10:00","pubTimestamp":1714874447,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳,王钰畅近期对爱尔眼科进行研究并发布了研究报告《业绩符合预期，经营韧性凸显》，本报告对爱尔眼科给出买入评级，当前股价为12.9元。 风险提示：医院收入或不及预期；行业政策风险；医疗事故风险。最新盈利预测明细如下：该股最近90天内共有14家机构给出评级，买入评级12家，增持评级2家；过去90天内机构目标均价为20.57。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050500000253.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430794205","title":"触及十年估值谷底，爱尔眼科否极泰来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2430794205","media":"格隆汇APP","top":-1,"share":"https://www.laohu8.com/m/news/2430794205?lang=zh_cn&edition=full","pubTime":"2024-04-27 16:15","pubTimestamp":1714205700,"startTime":"0","endTime":"0","summary":"刚刚发布2023年年报以及2024年一季报的爱尔眼科，其成绩单令人瞩目，股价也在当日呈现飘红态势，以3.19%的涨幅完美收官。截至2023年底，自公司上市以来，爱尔眼科已累计现金分红约56.34亿元，这一数字高达其IPO募集资金净额的6.4倍。其中，“1”是指将长沙爱尔打造成世界级眼科医学中心。截至2023年12月31日，爱尔眼科品牌医院、眼科中心及诊所在全球范围内共有875家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzAwNjExNDkyOA==&mid=2649851134&idx=2&sn=e2e2cc06510f5cd71af8a38b58a78c76&chksm=82615006a19fd53f7cf893b1aeab6485d2d3715bba349711aab04efb7259a3bb99b87b2ef63c&scene=0#rd","is_publish_highlight":false,"gpt_icon":0},{"id":"2430275626","title":"爱尔眼科：公司严格按照药监部门的要求，根据患者实际情况使用硫酸阿托品滴眼液院内制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2430275626","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430275626?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:01","pubTimestamp":1714132900,"startTime":"0","endTime":"0","summary":"公司严格按照药监部门的要求，根据患者实际情况使用硫酸阿托品滴眼液院内制剂。公司已经取得《医疗机构制剂许可证》以及0.05%硫酸阿托品滴眼液医疗机构制剂批件。公司按照有关法律法规履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600050521.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430247993","title":"平安证券：给予爱尔眼科增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430247993","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430247993?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:51","pubTimestamp":1714121495,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,李颖睿近期对爱尔眼科进行研究并发布了研究报告《业绩符合预期，公司门诊量快速增长》，本报告对爱尔眼科给出增持评级，当前股价为12.63元。考虑公司所处行业的良好发展前景，以及公司眼科医疗服务行业的龙头地位，我们维持公司的“推荐”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为24.76。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600037491.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430211809","title":"国金证券：给予爱尔眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430211809","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430211809?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:50","pubTimestamp":1714110642,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维近期对爱尔眼科进行研究并发布了研究报告《业绩彰显龙头韧性，海内外布局稳步推进》，本报告对爱尔眼科给出买入评级，当前股价为12.61元。 公司同时发布2024年一季报。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为24.76。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600027258.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430376572","title":"图解爱尔眼科一季报：第一季度单季净利润同比增15.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430376572","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430376572?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:47","pubTimestamp":1714067229,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科2024年一季报显示，公司主营收入51.96亿元，同比上升3.5%；归母净利润8.99亿元，同比上升15.16%；扣非净利润8.43亿元，同比上升12.04%；负债率32.28%，投资收益182.33万元，财务费用6194.39万元，毛利率48.29%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600002361.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430238057","title":"爱尔眼科(300015.SZ)发布一季度业绩，净利润8.99亿元 同比增加15.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430238057","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430238057?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:34","pubTimestamp":1714059267,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)发布2024年一季度报告，报告期内公司实现营业收入51.96亿元，同比增加3.5%;归属于上市公司股东的净利润8.99亿元，同比增加15.16%;归属于上市公司股东的扣除非经常性损益的净利润8.43亿元，同比增加12.04%;基本每股收益0.0976元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110942.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430785434","title":"4月25日爱尔眼科现1笔折价21.57%的大宗交易 合计成交240万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430785434","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430785434?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:33","pubTimestamp":1714034010,"startTime":"0","endTime":"0","summary":"证券之星消息，4月25日爱尔眼科发生大宗交易，交易数据如下：大宗交易成交价格9.6元，相对当日收盘价折价21.57%，成交25万股，成交金额240万元，买方营业部为中国中金财富证券有限公司上海分公司，卖方营业部为长城证券股份有限公司广东分公司。近三个月该股共发生9笔大宗交易，合计成交3.52万手，折价成交4笔。截至2024年4月25日收盘，爱尔眼科报收于12.24元，上涨2.34%，换手率1.24%，成交量98.01万手，成交额11.97亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500033218.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429916382","title":"4月23日爱尔眼科现1笔折价20.53%的大宗交易 合计成交240万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429916382","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429916382?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:47","pubTimestamp":1713862067,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日爱尔眼科发生大宗交易，交易数据如下：大宗交易成交价格9.6元，相对当日收盘价折价20.53%，成交25万股，成交金额240万元，买方营业部为中国中金财富证券有限公司上海分公司，卖方营业部为长城证券股份有限公司广东分公司。近三个月该股共发生8笔大宗交易，合计成交3.27万手，折价成交3笔。截至2024年4月23日收盘，爱尔眼科报收于12.08元，上涨0.83%，换手率0.98%，成交量77.43万手，成交额9.29亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031199.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429945170","title":"爱尔眼科：谢谢您对公司的关注和建议，我们会认真考虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2429945170","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429945170?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:02","pubTimestamp":1713780135,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科04月22日在投资者关系平台上答复投资者关心的问题。二级市场股价受多方面因素影响，公司经营健康，稳步发展。公司追求长远发展与即期回报的和谐统一，分红方案将综合考量来年投资额、财务安全性和股东获得感。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200021440.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912725","title":"4月22日爱尔眼科现1笔折价16.94%的大宗交易 合计成交308.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912725","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429912725?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:40","pubTimestamp":1713775254,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日爱尔眼科发生大宗交易，交易数据如下：大宗交易成交价格9.95元，相对当日收盘价折价16.94%，成交31万股，成交金额308.45万元，买方营业部为首创证券股份有限公司上海共和新路证券营业部，卖方营业部为国盛证券有限责任公司北京建国门外大街证券营业部。近三个月该股共发生7笔大宗交易，合计成交3.02万手，折价成交2笔。截至2024年4月22日收盘，爱尔眼科报收于11.98元，下跌1.32%，换手率1.07%，成交量84.24万手，成交额10.14亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200017167.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429405962","title":"脑机接口又传重磅利好！全球最大神经拟态系统诞生，比人脑快200倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2429405962","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2429405962?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:24","pubTimestamp":1713752640,"startTime":"0","endTime":"0","summary":"英特尔打开AGI时代的一把“钥匙”？","market":"sg","thumbnail":"https://img3.gelonghui.com/9112e-0d1877a9-cc43-44da-abd0-0da5aff2eb86.png?guru_height=291&guru_width=480","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9112e-0d1877a9-cc43-44da-abd0-0da5aff2eb86.png?guru_height=291&guru_width=480"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/722215","is_publish_highlight":false,"gpt_icon":0},{"id":"2409703971","title":"稳市场重心或转向成长？创大盘ETF（159991）逆市收涨4.06%，权重股爱尔眼科、宁德时代领衔反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2409703971","media":"新浪基金","top":-1,"share":"https://www.laohu8.com/m/news/2409703971?lang=zh_cn&edition=full","pubTime":"2024-02-05 16:44","pubTimestamp":1707122640,"startTime":"0","endTime":"0","summary":" 今日，两市走势分化，沪指、深成指跌逾1%，创业板指收涨0.79%，表征创业板优质成长白马走势的创业大盘指数收涨1.54%，表现强于创业板50、创成长等系列指数。 场内ETF方面，跟踪创业大盘指数的创大盘ETF尾盘持续走高，最终收涨4.06%，成交额1419万元，全天振幅高达9.38%！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-02-05/doc-inafynmh0690385.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-02-05/doc-inafynmh0690385.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2409203961","title":"医药、科技联袂齐升，创大盘ETF（159991）午后一度涨超5%！天孚通信、爱尔眼科等股涨逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409203961","media":"新浪基金","top":-1,"share":"https://www.laohu8.com/m/news/2409203961?lang=zh_cn&edition=full","pubTime":"2024-02-05 14:15","pubTimestamp":1707113700,"startTime":"0","endTime":"0","summary":" 午后，两市V字崛起，三大股指悉数翻红，创业板指涨近3%。盘面上，创业大盘指数涨近4%。成份股方面，天孚通信涨逾9%，智飞生物、爱尔眼科、华测检测、迈瑞医疗、爱美客等多股涨逾7%。 ETF方面，覆盖上述龙头股的创大盘ETF午后一度涨超5%，截至发文仍涨逾4%，日内振幅高达9.38%，高弹性特质较为突出。 兴业证券观点认为，方向比点位重要，TMT有望迎来超跌反弹的窗口。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-02-05/doc-inafyhck0784814.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-02-05/doc-inafyhck0784814.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2406234741","title":"爱尔眼科为何突现股价异动？","url":"https://stock-news.laohu8.com/highlight/detail?id=2406234741","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2406234741?lang=zh_cn&edition=full","pubTime":"2024-01-25 13:05","pubTimestamp":1706159100,"startTime":"0","endTime":"0","summary":" 今天上午出差，登机后就按照空姐的要求把手机设置为飞行模式，然后戴上眼罩，睡觉。这些天高速连轴转，缺觉。 回看十四五的历史，出现股价异动的情况很多，事后大家发现，从来没有一次是因为公司经营异常，这次也不例外！ 上市以来，每年总会出现几次股价异动的情况，有时可能是有人爆仓被动卖出股票，有时是因为假消息谬传误导市场……原因不一而足，但爱尔眼科没有一次业绩拉胯。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/cjzb/2024-01-25/doc-inaetiwm5454322.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/cjzb/2024-01-25/doc-inaetiwm5454322.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2393436014","title":"爱尔眼科：免去贵港爱尔CEO职务、暂停涉事医生院长职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2393436014","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2393436014?lang=zh_cn&edition=full","pubTime":"2023-12-22 08:13","pubTimestamp":1703203980,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月22日消息，针对贵港爱尔眼科医院“医生手术时捶打患者头部”一事，爱尔眼科医院昨夜在微博发布声明，表示涉事医生粗暴对待患者的行为，已严重违反医疗机构从业人员行为规范。集团已于21日下午免去贵港爱尔CEO职务，暂停院长（即手术医生）职务，两人均接受进一步调查。下一步，集团将敦促贵港爱尔深入整改，并将根据后续调查结果做进一步严肃处理。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：冯体炜","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2023-12-22/doc-imzyvvhk3865863.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2023-12-22/doc-imzyvvhk3865863.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2393436418","title":"爱尔眼科深夜声明！免去贵港爱尔CEO职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2393436418","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/2393436418?lang=zh_cn&edition=full","pubTime":"2023-12-22 07:52","pubTimestamp":1703202720,"startTime":"0","endTime":"0","summary":" 爱尔眼科医院深夜发布声明！ 近日，贵港爱尔眼科医生“手术台拳打患者头部”视频引发舆论关注，爱尔眼科医院集团对此高度重视，迅速成立调查组进驻贵港爱尔，对此事进行复核调查。 与此同时，调查组初步认定，贵港爱尔眼科医院还存有其他严重违反集团规定的问题，应承担相应责任。 根据以上事实，集团已于今日下午免去贵港爱尔CEO职务，暂停院长职务，两人均接受进一步调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/2023-12-22/doc-imzyvvhf4322108.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2023-12-22/doc-imzyvvhf4322108.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2393103378","title":"深陷舆论漩涡，爱尔眼科的“眼科帝国”还好吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2393103378","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2393103378?lang=zh_cn&edition=full","pubTime":"2023-12-21 19:24","pubTimestamp":1703157882,"startTime":"0","endTime":"0","summary":"近期，一则关于“爱尔眼科医生在手术台上对患者头部实施拳击”的视频在网络上广泛传播，引起广泛关注和热议。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202312_1/6e436b33-e01f-4f73-9e9e-c90ad3243705.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202312_1/6e436b33-e01f-4f73-9e9e-c90ad3243705.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6584207abde0b375aabeafd2","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","stockEarnings":[{"period":"1week","weight":0.0248},{"period":"1month","weight":0.0201},{"period":"3month","weight":-0.0537},{"period":"6month","weight":-0.2668},{"period":"1year","weight":-0.4053},{"period":"ytd","weight":-0.1643}],"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","perCapita":"23358股","boardName":"卫生","registeredCapital":"932841万元","compareEarnings":[{"period":"1week","weight":0.0138},{"period":"1month","weight":0.0256},{"period":"3month","weight":0.1124},{"period":"6month","weight":0.0309},{"period":"1year","weight":-0.0728},{"period":"ytd","weight":0.0581}],"survey":" 爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。","serverTime":1715125801129,"listedPrice":28,"stockholders":"338428人(较上一季度增加8.24%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}